These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25770192)

  • 1. Comparative proteomic analysis of two stress-management strategies in pancreatic cancer.
    Baron B; Fujioka T; Kitagawa T; Maehara S; Maehara Y; Nakamura K; Kuramitsu Y
    Cancer Genomics Proteomics; 2015; 12(2):83-7. PubMed ID: 25770192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environment.
    Baron B; Kitagawa T; Nakamura K; Kuramitsu Y
    Cancer Genomics Proteomics; 2015; 12(2):49-55. PubMed ID: 25770187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
    Kuramitsu Y; Taba K; Ryozawa S; Yoshida K; Zhang X; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2010 Sep; 30(9):3367-72. PubMed ID: 20944110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells.
    Suenaga S; Kuramitsu Y; Wang Y; Baron B; Kitagawa T; Akada J; Tokuda K; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2013 Nov; 33(11):4821-6. PubMed ID: 24222118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells.
    Kuramitsu Y; Suenaga S; Wang Y; Tokuda K; Kitagawa T; Tanaka T; Akada J; Maehara S; Maehara Y; Nakamura K
    Anticancer Res; 2013 Aug; 33(8):3133-6. PubMed ID: 23898070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.
    Mori-Iwamoto S; Kuramitsu Y; Ryozawa S; Mikuria K; Fujimoto M; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
    Int J Oncol; 2007 Dec; 31(6):1345-50. PubMed ID: 17982661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.
    Kuramitsu Y; Wang Y; Kitagawa T; Tokuda K; Akada J; Tokunaga M; Nakamura K
    Anticancer Res; 2015 Jul; 35(7):3861-5. PubMed ID: 26124331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.
    Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Mori-Iwamoto S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Chemotherapy; 2011; 57(1):12-6. PubMed ID: 21124027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.
    Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2010 Jul; 30(7):2539-43. PubMed ID: 20682980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells.
    Maehara S; Tanaka S; Shimada M; Shirabe K; Saito Y; Takahashi K; Maehara Y
    Int J Cancer; 2004 Nov; 112(2):184-9. PubMed ID: 15352029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.
    Suenaga S; Kuramitsu Y; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2014 Jan; 34(1):141-6. PubMed ID: 24403454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action.
    Baron B; Wang Y; Maehara S; Maehara Y; Kuramitsu Y; Nakamura K
    Anticancer Res; 2015 Apr; 35(4):1941-9. PubMed ID: 25862846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses.
    Liu QH; Zhao CY; Zhang J; Chen Y; Gao L; Ni CY; Zhu MH
    Mol Med Rep; 2012 Oct; 6(4):767-73. PubMed ID: 22858734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells.
    Chen YW; Liu JY; Lin ST; Li JM; Huang SH; Chen JY; Wu JY; Kuo CC; Wu CL; Lu YC; Chen YH; Fan CY; Huang PC; Law CH; Lyu PC; Chou HC; Chan HL
    Mol Biosyst; 2011 Nov; 7(11):3065-74. PubMed ID: 21894339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
    Tokunaga M; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
    Anticancer Res; 2015 Nov; 35(11):6063-7. PubMed ID: 26504030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells.
    Shimada T; Nanimoto Y; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
    In Vivo; 2018; 32(4):759-763. PubMed ID: 29936456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells.
    Wang Y; Kuramitsu Y; Baron B; Kitagawa T; Tokuda K; Akada J; Maehara SI; Maehara Y; Nakamura K
    Int J Oncol; 2017 Feb; 50(2):606-612. PubMed ID: 28000865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells.
    Kuhara K; Tokuda K; Kitagawa T; Baron B; Tokunaga M; Harada K; Terasaki M; Uehara O; Ohta T; Takai R; Hamada JI; Kobayashi M; Shimo T; Nagayasu H; Kuramitsu Y
    Anticancer Res; 2018 Nov; 38(11):6107-6111. PubMed ID: 30396925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer.
    Jakstaite A; Maziukiene A; Silkuniene G; Kmieliute K; Gulbinas A; Dambrauskas Z
    World J Gastroenterol; 2015 Dec; 21(46):13004-19. PubMed ID: 26675757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
    Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
    BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.